Heron Therapeutics
HRTX
#8076
Rank
NZ$0.31 B
Marketcap
$2.06
Share price
-5.47%
Change (1 day)
120.82%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.94

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.00. In 2022 the company made an earnings per share (EPS) of -$2.95 an increase over its 2021 EPS that were of -$3.84.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.94-34.38%
2022-$2.95-23.11%
2021-$3.84-10%
2020-$4.27-0%
2019-$4.271.21%
2018-$4.21-32.7%
2017-$6.26-19.34%
2016-$7.7654.76%
2015-$5.021.73%
2014-$4.93-16.23%
2013-$5.8991.67%
2012-$3.07-31.45%
2011-$4.48-27.06%
2010-$6.14-43.75%
2009-$10.92-57.33%
2008-$25.59-82.92%
2007-$149.8120.61%
2006-$124.21175.76%
2005-$45.04-21.43%
2004-$57.33100%
2003-$28.66-38.24%
2002-$46.41161.54%
2001-$17.74-106.46%
2000$274.522051.55%
1999$12.76839.73%
1998$1.36-105.48%
1997-$24.79-88.16%
1996-$209.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.22-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.24-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.78 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.68-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.82 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA